Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Tumor Biology

• Publication date

  2014-09-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-014-2533-5PMID 25195131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2014

  2014cited by this paper
• Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer

  2014cited by this paper
• Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles

  2014cited by this paper
• Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.

  2013cited by this paper
• Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers

  2013cited by this paper
• Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.

  2013cited by this paper
• Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer

  2013cited by this paper
• Circulating microRNAs in plasma as early detection markers for breast cancer

  2013cited by this paper
• Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection

  2013cited by this paper
• Decreased serum miR-181a is a potential new tool for breast cancer screening.

  2012cited by this paper
• Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer

  2012cited by this paper
• Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.

  2012cited by this paper
• Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

  2012cited by this paper
• The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors

  2012cited by this paper
• Analysis of serum genome-wide microRNAs for breast cancer detection.

  2012cited by this paper
• Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection

  2012cited by this paper
• QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

  2011cited by this paper
• MicroRNA expression profiling in human Barrett's carcinogenesis

  2011cited by this paper
• A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer

  2010cited by this paper
• Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

  2010cited by this paper
• Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

  2010cited by this paper
• Clinical diagnosis of depression in primary care: a meta-analysis.

  2009cited by this paper
• Role of tumor markers in patients with solid cancers: A critical review.

  2007cited by this paper
• Bmc Medical Research Methodology Open Access Motor Function in Parkinson's Disease and Supranuclear Palsy: Simultaneous Factor Analysis of a Clinical Scale in Several Populations

  2006cited by this paper
• Synthesizing medical evidence: systematic reviews and metaanalyses.

  2005cited by this paper
• Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation.

  2005cited by this paper
• Estimates of cancer incidence in China for 2000 and projections for 2005.

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

  2005cited by this paper
• Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests.

  2005cited by this paper
• A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• The diagnostic odds ratio: a single indicator of test performance.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Limitations of tumour markers in screening

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells.

  1986cited by this paper

• miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis.

  2024cites this paper
• Plasma microRNA ratios associated with breast cancer detection in a nested case–control study from a mammography screening cohort

  2023cites this paper
• Modern mRNA-based molecular diagnostics for prediction of urothelial carcinoma behavior

  2023cites this paper
• Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis

  2023cites this paper
• Cell-free circulating miRNAs-lncRNAs-mRNAs as predictive markers for breast cancer risk assessment in women exposed to indoor air pollution

  2022cites this paper
• Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection

  2022influential citation
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients

  2022cites this paper
• Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy

  2020cites this paper
• Classification of heterogeneous genetic variations of microRNA regulome in cancer.

  2018cites this paper
• The future of blood-based biomarkers for the early detection of breast cancer.

  2018cites this paper
• Classification of miRNA-related sequence variations.

  2018cites this paper
• Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer: A pooled analysis of individual studies

  2018cites this paper
• MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis

  2017cites this paper
• Breast Cancer Biomarkers in Circulation

  2017cites this paper
• The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis

  2017cites this paper
• Meta-Analysis of microRNAs as Potential Biomarkers for Detecting Esophageal Carcinoma in Asian Populations

  2017cites this paper
• HNF-4α regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells.

  2016cites this paper
• Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway

  2016cites this paper
• Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.

  2016cites this paper
• Thinking Small: Circulating microRNAs as Novel Biomarkers for Diagnosis, Prognosis, and Treatment Monitoring in Breast Cancer

  2016cites this paper
• The biomarker and therapeutic potential of miRNA in Alzheimer's disease.

  2015cites this paper
• The Diagnostic and Therapeutic Application of Circulating microRNAs in Breast Cancer

  2015cites this paper
• 循环microRNAs在乳腺癌诊治中的应用 The Diagnostic and Therapeutic Application of Circulating microRNAs in Breast Cancer

  2015cites this paper